Last reviewed · How we verify

NCT06941246: prolactin

Prolactin Levels in Type 2 Diabetic Patients With Stage III Periodontitis

Completed NA Last updated 23 April 2025
What this trial tests

NA trial testing Non Surgical Periodontal Treatment in Type 2 Diabetes Mellitus in 80 participants. Completed in 1 April 2025.

Timeline
1 October 2024
Primary endpoint
1 January 2025
1 April 2025

Quick facts

Lead sponsorFaculty of Dental Medicine for Girls
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment80
Start date1 October 2024
Primary completion1 January 2025
Estimated completion1 April 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Dental Medicine for Girls — full company profile →

Who can join

Adults 18 to 60, any sex, with Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluate the role of prolactin hormone in the pathogenesis of periodontitis by assessing its local gingival levels and assess clinical parameters in patients who have type two diabetes

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Non Surgical Periodontal Treatment

Trials testing the same drug.

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

Other Faculty of Dental Medicine for Girls trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06941246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing